Loading...

Purified anti-Tubulin β-3 (TUBB3) Antibody (Previously Covance catalog# PRB-435P)

Pricing & Availability
Clone
Poly18020 (See other available formats)
Regulatory Status
RUO
Other Names
CDCBM, CDCBM1, CFEOM3, CFEOM3A, FEOM3, TUBB4, Tubulin beta-3 chain, tubulin beta-III, TUBB3, tubulin beta-4 chain, class III beta-tubulin
Previously
Covance Catalog# PRB-435P
Isotype
Rabbit Polyclonal IgG
Ave. Rating
Submit a Review
Product Citations
publications
A_Poly18020_PURE_Tubulin_beta3_IHCP_1_032918
IHC staining of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020) on formalin-fixed paraffin-embedded rat cerebellum. Following antigen retrieval using Sodium Citrate H.I.E.R., the tissue was incubated with 0.1 µg/mL of the primary antibody overnight at 4°C. BioLegend’s Ultra Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • A_Poly18020_PURE_Tubulin_beta3_IHCP_1_032918
    IHC staining of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020) on formalin-fixed paraffin-embedded rat cerebellum. Following antigen retrieval using Sodium Citrate H.I.E.R., the tissue was incubated with 0.1 µg/mL of the primary antibody overnight at 4°C. BioLegend’s Ultra Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • B_Poly18020_PURE_Tubulin_beta3_IHCP_2_032918
    IHC staining of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020) on formalin-fixed paraffin-embedded human cerebellum. Following antigen retrieval using Sodium Citrate H.I.E.R., the tissue was incubated with 0.1 µg/mL of the primary antibody overnight at 4°C. BioLegend’s Ultra Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • C_Poly18020_PURE_Tubulin_beta3_IHCP_3_032918
    IHC staining of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020) on formalin-fixed paraffin-embedded human cerebellum. Following antigen retrieval using Sodium Citrate H.I.E.R., the tissue was incubated with 0.1 µg/mL of the primary antibody overnight at 4°C. BioLegend’s Ultra Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • Poly18020_PURE_Tubulin_beta3_WB_021915.jpg
    Western blot of purified anti-Tubulin β-3 (TUBB3) antibody (Poly18020). Lane 1: Molecular weight marker; Lane 2: 20 µg of human brain lysate; Lane 3: 20 µg of mouse brain lysate; Lane 4: 20 µg of rat brain lysate. The blots were incubated with 0.1 µg/mL of Poly18020 or Rabbit IgG overnight at 4°C, followed by incubation with HRP-labeled anti-rabbit IgG (Cat. No. 410406). Enhanced chemiluminescence was used as the detection system.
Cat # Size Price Quantity Check Availability Save
802001 100 µL $433
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Tubulin is the main component of microtubules. In adults, tubulin beta 3 (TUBB3) is primarily expressed in neurons and is commonly used as a neuronal marker. It plays an important role in neuronal cell proliferation and differentiation. Mutations in this gene cause congenital fibrosis of the type 3 extraocular muscles. Tubulin beta 3 (TUBB3) is also found in a wide range of tumors. Studies indicate that it is a predictive and prognostic marker in various tumors.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human, Mouse, Rat
Antibody Type
Polyclonal
Host Species
Rabbit
Immunogen
This antibody was raised against microtubules derived from rat brain.
Formulation
Phosphate-buffered solution + 0.03% Thimerosal + 50% Glycerol.
Preparation
The antibody was purified by affinity chromatography.
Concentration
1.0 mg/ml
Storage & Handling
Store between 2°C and 8°C.
Application

IHC-P - Quality tested
WB - Verified
ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemistry, a concentration range of 0.1 - 0.5 µg/mL is suggested. For Western blotting, the suggested use of this reagent is 0.1 - 0.5 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunocytochemistry (ICC).

This antibody is well characterized and highly reactive to neuron specific Class III ß-Tubulin (ßIII), but does not identify ß-tubulin found in glial cells. This product may contain other non-IgG subtypes.

Application References

(PubMed link indicates BioLegend citation)
  1. Feuer R, et al. 2005. J. Neurosci. 25(9):2434-44.
  2. Mozzetti S, et al. 2005. Clin. Cancer Res. 11(1):298-305.
  3. Feuer R, et al. 2003. Am. J. Pathol. 163(4):1379-93.
  4. Zhang XM, Yang XJ. 2001. Development. 128(6):943-57.
  5. Ma M, et al. 2012. Neurobiol Dis. 56:34. (WB) PubMed
  6. Tseung G, et al. 2011. J. Virol. 85:5718. (IF) PubMed
  7. Shimada IS, et al. 2012. J Neurosci. 32:7926. (IHC) PubMed
  8. Flores-Otero J, et al. 2007. J. Neurosci. 27:14023. (IF) PubMed
Product Citations
  1. Ahangari N, et al. 2021. J Neuropathol Exp Neurol. 80:944. PubMed
  2. Samarasinghe RA, et al. 2021. Nat Neurosci. 24:1488. PubMed
  3. Chow A, Morshead C 2016. Stem Cell Res. 16:79-87. PubMed
  4. Son M, et al. 2016. Exp Mol Med. 48: 232. PubMed
  5. Hoshino N, et al. 2021. Journal of Comparative Neurology. 529:3633. PubMed
  6. Tseng K, et al. 2017. eNeuro. 10.1523/ENEURO.0214-17.2017. PubMed
  7. Eltahir MK, et al. 2022. PLoS One. 17:e0269683. PubMed
  8. Pardieck J, et al. 2021. Stem Cells Dev. 30:816. PubMed
  9. Kim S, et al. 2021. Nat Commun. 12:1807. PubMed
  10. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  11. Tian E, et al. 2016. Cell Rep. 16: 781-792. PubMed
  12. Baleriola J, et al. 2016. Sci Rep. 6: 25928. PubMed
  13. Shimada I, et al. 2012. J Neurosci. 32:7926-7940. PubMed
  14. Arber C, et al. 2019. Brain Commun. 1:fcz024. PubMed
  15. Jiang Y, et al. 2018. J Biol Chem. 293:19317. PubMed
  16. Stokowska A, et al. 2017. Brain. 140:353. PubMed
  17. Meng QT, et al. 2021. Elife. 10:. PubMed
  18. Olmsted ZT, et al. 2022. Front Cell Neurosci. 15:725195. PubMed
  19. Binder J, et al. 2022. Commun Biol. 5:125. PubMed
  20. Krishnan V, et al. 2016. J Neuropathol Exp Neurol. 75: 464 - 478. PubMed
  21. Brosig A, et al. 2019. Cell Rep. 29:2028. PubMed
  22. Girouard MP, et al. 2020. eneuro. 7(2):ENEURO. PubMed
  23. Vogt M, et al. 2021. Theranostics. 11:5569. PubMed
  24. Pires G, et al. 2021. Brain Commun. 3:fcab021. PubMed
  25. Nichterwitz S, et al. 2020. Genome Res. 30:1083. PubMed
  26. Brykczynska U, et al. 2016. Stem Cell Reports. 7:1059-1071. PubMed
  27. Omichi R, et al. 2020. Mol Ther Methods Clin Dev. 1.51875. PubMed
  28. Xie Y, et al. 2018. Stem Cell Res. 9:2010. PubMed
  29. Uezono N, et al. 2018. Stem Cells. 36:737. PubMed
  30. Tang SC, et al. 2017. Diabetologia. 61:158. PubMed
  31. MOSES C, et al. 2020. Sci Rep. 10:11393. PubMed
  32. Nayak G, et al. 2020. Cell Reports. 30(3):672-686.e8.. PubMed
  33. Dvoriantchikova G, et al. 2022. Sci Rep. 12:17152. PubMed
  34. Jo S, et al. 2021. Stem Cell Research. 56:102524. PubMed
  35. Gong C, et al. 2021. Cell Reports. 34(12):108889. PubMed
  36. Kurihara Y, et al. 2020. Journal of Neurochemistry. 155(3):285-299. PubMed
  37. Hastings RL, et al. 2020. Sci Rep. 10:11132. PubMed
  38. Hoffman LF, et al. 2018. J Assoc Res Otolaryngol. 19:33. PubMed
  39. Carlin D et al. 2018. eNeuro. 5(2) pii: ENEURO. PubMed
  40. Mertens J, et al. 2021. Cell Stem Cell. 28:1533. PubMed
  41. Boland M, et al. 2017. Brain. 10.1093/brain/aww357. PubMed
  42. Ou MY, et al. 2021. Cell Reports. 35(13):109290. PubMed
  43. Sakaguchi H, et al. 2019. Stem Cell Reports. 13:458. PubMed
  44. Voronova A et al. 2017. Neuron. 94(3):500-516 . PubMed
  45. Sabelström H, et al. 2019. Cell Rep. 28:2064. PubMed
  46. van Niekerk EA, et al. 2022. Cell Rep Methods. 2:100255. PubMed
  47. Avraham O, et al. 2021. Elife. 10:. PubMed
  48. Simone R, et al. 2021. Nature. 594:117. PubMed
  49. Lasagni Vitar RM, et al. 2021. Invest Ophthalmol Vis Sci. 62:26. PubMed
  50. Reddy A, et al. 2020. Cell. 183:62. PubMed
  51. Otani T, et al. 2016. Cell Stem Cell. 18: 467-480. PubMed
  52. Verstraelen P, et al. 2017. Front Cell Neurosci. 11:173. PubMed
  53. Kim H et al. 2017. Stem cell research. 26:72-75 . PubMed
  54. Li H, et al. 2019. iScience. 19:559. PubMed
  55. Macpherson P, et al. 2015. Development. 142: 4038 - 4048. PubMed
  56. Ferguson M, et al. 2013. Neurobiol Dis. 56:34-46. PubMed
  57. Yau K, et al. 2016. J Neurosci. 36: 1071 - 1085. PubMed
  58. Cui Q, et al. 2016. Nat Commun. 7:10637. PubMed
  59. Bosze B, et al. 2020. J Neurosci. 40:1501. PubMed
  60. Benoy V, et al. 2018. Brain. 10.1093/brain/awx375. PubMed
  61. Chabrat A, et al. 2019. Stem Cells Int. 2019:2945435. PubMed
  62. Yang C, et al. 2020. Neuron. 105:276. PubMed
  63. Suter TACS, et al. 2020. Cell Rep. 30:1164. PubMed
  64. Adams MT, et al. 2021. eLife. 0.416666666666667. PubMed
  65. Iannielli A, et al. 2019. Cell Rep. 29:4646. PubMed
  66. Bowles KR, et al. 2019. PLoS One. 14:e0213374. PubMed
  67. Toda T, et al. 2017. Cell Stem Cell. 21:618. PubMed
  68. Qiang L et al. 2018. Current biology : CB. 28(13):2181-2189 . PubMed
  69. Meijer M et al. 2019. Cell Rep. 27(7):2199-2211 . PubMed
  70. Finno CJ, et al. 2022. Front Cell Neurosci. 16:853035. PubMed
  71. Newland B, et al. 2021. ACS Chem Neurosci. 12:1178. PubMed
  72. Amador A, et al. 2020. Brain. 143:2039. PubMed
  73. Sugiyama T, et al. 2021. iScience. 24(7):102758. PubMed
  74. Bhaskaran S, et al. 2020. Aging Cell. 19:e13225. PubMed
  75. Rhee HJ et al. 2019. Cell Rep. 27(7):2212-2228 . PubMed
  76. Makar T, et al. 2018. Stem Cell Res Ther. 9:127. PubMed
  77. Zahr SK et al. 2018. Neuron. 97(3):520-537 . PubMed
  78. Cora V, et al. 2019. Cells. 8:5. PubMed
  79. Grove M, et al. 2020. eLife. 9:e50138.. PubMed
  80. Francistiová L, et al. 2022. Front Mol Neurosci. 14:793769. PubMed
  81. Iennaco R, et al. 2022. Cell Death Differ. 29:293. PubMed
  82. Bjorke B, et al. 2021. Dev Biol. 476:272. PubMed
  83. Huang S, et al. 2020. Cell. 184(2):441-459.e25. PubMed
  84. Lin P, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G412 - G422. PubMed
  85. Tsueng G, et al. 2011. J Virol. 85:5718-5732. PubMed
  86. Alvarez–Lindo N, et al. 2019. Sci Rep. 9:18486. PubMed
  87. Tiwari D et al. 2019. Neurobiol Dis. 1871:48:00 . PubMed
  88. Carlin D et al. 2019. eNeuro. 6(3) pii: ENEURO. PubMed
  89. Li H, et al. 2018. Hum Mutat. 39:550. PubMed
  90. Smith LA, et al. 2021. Front Cell Dev Biol. 9:667246. PubMed
  91. Mao Y, et al. 2021. Cell Prolif. 54:e13090. PubMed
  92. Olmsted ZT, et al. 2022. iScience. 25:104486. PubMed
  93. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  94. Watanabe S, et al. 2016. EMBO Mol Med. 8(12):1421-1437. PubMed
  95. Cates K, et al. 2020. Cell Stem Cell. 28(1):127-140.e9. PubMed
  96. Ou J et al. 2018. Cell. 173(4):851-863 . PubMed
  97. Hsu J, et al. 2019. Nat Commun. 10:2939. PubMed
  98. Chanda S et al. 2019. Cell Stem Cell. 25(1):103-119 . PubMed
  99. Peitz M, et al. 2020. STAR Protoc. 1:100038. PubMed
  100. Flitsch LJ, et al. 2022. Sci Rep. 12:8356. PubMed
  101. Pahl MC, et al. 2021. Nat Commun. 12:6749. PubMed
  102. Kim H, et al. 2020. Sci Signal. 13: . PubMed
  103. Vicidomini C, et al. 2016. Mol Psychiatry. 10.1038/mp.2016.30. PubMed
  104. Barry DM, et al. 2020. Nat Commun. 11:1397. PubMed
  105. Hattori Y, et al. 2020. Nat Commun. 11:1631. PubMed
  106. Duncan DS, et al. 2018. Front Neurosci. 0.9875. PubMed
  107. Martínez JC et al. 2019. Neuron. 104(5):931-946 . PubMed
  108. Mickle AD, et al. 2019. Nature. 565:361. PubMed
  109. Kawakami Y et al. 2018. The Journal of Neuroscience. 38(10):2589-2604 . PubMed
  110. Flores-Otero J, et al. 2007. J Neurosci. 27:14023-14034. PubMed
  111. Zhang L, et al. 2016. Neuroscience. 337:88-97. PubMed
  112. Arber C, et al. 2021. Cell Reports. 34(2):108615. PubMed
  113. Shah K, et al. 2019. J Mol Cell Biol. N/A. PubMed
  114. Sar Shalom H, et al. 2019. Elife. 8:e41162. PubMed
  115. Facchin C, et al. 2020. Theranostics. 10:3518. PubMed
  116. Baker L, et al. 2021. JCI Insight. 6:. PubMed
  117. Besusso D, et al. 2020. Stem Cell Res. 102016:49. PubMed
  118. Shang Y, et al. 2018. J Neurosci. 38:4006. PubMed
  119. Jean-Louis T, et al. 2018. Neurobiol Aging. 62:130. PubMed
  120. Dan W, et al. 2022. Front Physiol. 12:744294. PubMed
  121. Avraham O, et al. 2022. Front Mol Neurosci. 14:796070. PubMed
  122. Jacob L, et al. 2022. J Exp Med. 219:. PubMed
  123. Arber C, et al. 2020. Mol Psychiatry. 25:2919. PubMed
  124. Smith-Anttila CJA, et al. 2021. Developmental Biology. 476:18-32. PubMed
  125. Hung C, et al. 2021. Cell Reports. 35(11):109259. PubMed
  126. Ornaghi F, et al. 2020. Neurobiol Dis. 134:104667. PubMed
  127. Hung COY et al. 2018. Cell reports. 25(13):3647-3660 . PubMed
  128. Jeon H, et al. 2018. J Clin Med. 7:. PubMed
  129. Avraham O, et al. 2022. Front Mol Neurosci. 15:967472. PubMed
  130. Su Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  131. Olmsted ZT, et al. 2021. iScience. 24(8):102827. PubMed
  132. Ward AI, et al. 2020. MBio. 11:00. PubMed
  133. Avraham O, et al. 2020. Nat Commun. 3.854861111. PubMed
  134. Anastasiadou S, Knöll B 2016. Exp Neurol. 279:243-260. PubMed
  135. Lee J, et al. 2018. J Clin Med. 7:. PubMed
RRID
AB_2564645 (BioLegend Cat. No. 802001)

Antigen Details

Cell Type
Mature Neurons, Neural Stem Cells
Biology Area
Cell Biology, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
Microtubules
Gene ID
10381 View all products for this Gene ID
UniProt
View information about Tubulin beta-3 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 10/24/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account